The seasonal flu vaccine is not expected to protect against the 2009 H1N1 flu. Similarly, the 2009 H1N1 influenza vaccine will not protect against seasonal influenza

Alliance Medical Group is prepared to treat our patients who are candidates for the H1N1 vaccine as well as those who have been exposed to or have come down with the H1N1 Influenza virus. Do not hesitate to contact our office to speak with one of our providers or nurses about the H1N1 vaccine, how the H1N1 virus is spread and steps to take to reduce infection with the virus. Please see below for the State of Connecticut restrictions for priority populations.

Click here for the latest information from the CDC.

Please note:

• All Alliance Medical group Internal Medicine offices are out of the regular seasonal flu vaccine, and we are not expecting further vaccine due to manufacturer supply.
• All of our offices are currently scheduling H1N1 flu vaccinations. Please call our office for more information.

Instructions from the State of Connecticut Department of Public Health dated December 14, 2009.

Alliance Medical group continues to receive shipments of the Influenza A(H1N1) vaccine. The two types of vaccine being manufactured are the Live H1N1 Influenza Vaccine (intranasal spray) which is indicated for healthy individuals 2-49 years of age who are NOT pregnant and the Inactivated Injectable H1N1 Influenza Vaccine. Please follow the above link to the CDC website for more detailed information regarding H1N1 updates. Supplies are limited so please contact the office for the most current availability.

The H1N1 vaccine priority groups are re-evaluated and updated as the state receives more H1N1 vaccine. The priority populations are as follows:

Alliance Medical Group received a memo from the state of Connecticut stating that we can now administer the H1N1 vaccine to anyone who wishes to receive it. Vaccine is no longer restricted to the previous outlined priority groups.

The injectable form of H1N1 vaccine is still in short supply. Healthy persons aged 2 through 49 years should consider using the Intranasal H1N1(LAIV) vaccine if available.

Medical conditions that confer a higher risk for influenza-related complications include chronic pulmonary (including asthma), cardiovascular (except hypertension), renal, hepatic, cognitive, neurologic/neuromuscular, hematologic, or metabolic disorders (including diabetes mellitus) and immunosuppression (including immunosuppression caused by medications or by human immunodeficiency virus). If you have additional questions and for a complete list, please visit http://www.cdc.gov/h1n1flu/highrisk.htm

The State is asking our office to honor the priority groups identified above. Not all H1N1 vaccine products are currently available in sufficient quantity. Given this information, we are doing our best to vaccinate as many patients as possible. Thank you in advance for your patience.